Security
BIO GREEN MED SOLUTION INC · CYCC
CYCCOTCCommon stockHistorical · closed Sep 11, 2025CIK 1130166Updated Oct 27, 2026
Name history
Cyclacel Pharmaceuticals, Inc. · through Sep 12, 2025XCYTE THERAPIES INC · through Mar 24, 2006
Current security for this SEC filerBGMS · NASDAQ
CYCC price & chart
Historical security
This listing closed Sep 11, 2025. Live provider charts are shown only for current listings.
Current security: BGMS
About the company
We are a clinical-stage biopharmaceutical company working to develop innovative cancer medicines based on cell cycle, epigenetics and mitosis biology. We are a pioneer company in the field of cancer cell cycle biology with a vision to improve patient healthcare by translating insights in cancer biology into medicines that can overcome resistance and ultimately increase a patient’s overall survival.
In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q3 2023 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 8,158,000Source | 5,381,000Source | 12,497,000Source | 7,854,000Source | 4,401,000Source | 7,564,000Source | 3,734,000Source | 6,165,000Source | 8,185,000Source | 4,094,000Source | 8,805,000Source | 40,178,000Source |
| Property, Plant and Equipment, NetUSD | 129,000Source | 4,000Source | 16,000Source | 136,000Source | 1,000Source | 138,000Source | 1,000Source | 7,000Source | 137,000Source | 3,000Source | 9,000Source | — |
| GoodwillUSD | 1,569,656,000Source | — | — | 1,570,000Source | — | 1,570,000Source | — | — | 1,570,000Source | — | — | — |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 3,838,000Source | 2,982,000Source | 5,944,000Source | 3,790,000Source | 4,275,000Source | 3,339,000Source | 3,450,000Source | 2,798,000Source | 3,505,000Source | 3,137,000Source | 3,378,000Source | — |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 725,000Source | — | — | 1,074,000Source | — | 1,188,000Source | — | — | 1,257,000Source | — | — | — |
| Inventory, NetUSD | 1,368,000Source | — | — | 972,000Source | — | 947,000Source | — | — | 1,384,000Source | — | — | — |
| Assets, CurrentUSD | 6,444,000Source | 4,913,000Source | 11,113,000Source | 5,969,000Source | 4,383,000Source | 5,622,000Source | 3,714,000Source | 4,835,000Source | 6,256,000Source | 3,674,000Source | 7,444,000Source | — |
| Prepaid Expense and Other Assets, CurrentUSD | 513,000Source | 1,931,000Source | 5,169,000Source | 133,000Source | 108,000Source | 148,000Source | 264,000Source | 2,037,000Source | 110,000Source | 537,000Source | 4,066,000Source | — |
| Operating Lease, Right-of-Use AssetUSD | 15,000Source | 51,000Source | 109,000Source | 7,000Source | 17,000Source | 10,000Source | 19,000Source | 79,000Source | 12,000Source | 5,000Source | 93,000Source | — |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 1,062,000Source | 6,351,000Source | 8,200,000Source | 694,000Source | 770,000Source | 804,000Source | 672,000Source | 8,371,000Source | 1,343,000Source | 6,268,000Source | 8,198,000Source | 6,338,000Source |
| Stockholders’ equity: | ||||||||||||
| Common Stock, Value, IssuedUSD | 3,000Source | 2,000Source | 12,000Source | 7,000Source | 2,000Source | 5,000Source | 204,000Source | 1,000Source | 5,000Source | 9,000Source | 1,000Source | — |
| Additional Paid in CapitalUSD | 451,354,000Source | 436,503,000Source | 428,464,000Source | 462,166,000Source | 445,405,000Source | 461,393,000Source | 443,318,000Source | 429,919,000Source | 461,287,000Source | 438,211,000Source | 429,796,000Source | — |
| Retained Earnings (Accumulated Deficit)USD | -444,261,000Source | -436,442,000Source | -423,011,000Source | -455,013,000Source | -441,779,000Source | -454,608,000Source | -440,461,000Source | -431,228,000Source | -454,411,000Source | -439,494,000Source | -428,282,000Source | -388,637,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | — | -1,033,000Source | -1,168,000Source | — | — | -30,000Source | — | -898,000Source | -39,000Source | -891,000Source | -908,000Source | — |
| Stockholders' Equity Attributable to ParentUSD | 7,096,000Source | -970,000Source | 4,297,000Source | 7,160,000Source | 3,631,000Source | 6,760,000Source | 3,062,000Source | -2,206,000Source | 6,842,000Source | -2,174,000Source | 607,000Source | 33,840,000Source |
| Liabilities and EquityUSD | 8,158,000Source | 5,381,000Source | 12,497,000Source | 7,854,000Source | 4,401,000Source | 7,564,000Source | 3,734,000Source | 6,165,000Source | 8,185,000Source | 4,094,000Source | 8,805,000Source | 40,178,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 1,002,000Source | 6,351,000Source | 8,148,000Source | 692,000Source | 760,000Source | 796,000Source | 663,000Source | 8,350,000Source | 1,332,000Source | 6,268,000Source | 8,161,000Source | 6,323,000Source |
| Accounts Payable, CurrentUSD | 468,000Source | 4,126,000Source | 1,571,000Source | 189,000Source | 221,000Source | 256,000Source | 114,000Source | 5,200,000Source | 617,000Source | 4,599,000Source | 3,543,000Source | — |
| Operating Lease, Liability, NoncurrentUSD | 5,000Source | 0Source | 52,000Source | — | 10,000Source | — | 9,000Source | 21,000Source | 2,000Source | 0Source | 37,000Source | — |
| Additional Financial Items | ||||||||||||
| Accrued Liabilities, CurrentUSD | 534,000Source | 2,225,000Source | 6,577,000Source | 503,000Source | 539,000Source | 540,000Source | 549,000Source | 3,150,000Source | 715,000Source | 1,669,000Source | 4,618,000Source | 3,473,000Source |
| Preferred Stock, Value, Issued | — | — | —Source | — | — | — | — | — | — | — | — | — |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | — | -81,000Source | — | -11,212,000Source | — | — |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 1,000Source | 1,666,000Source | 2,334,000Source | 592,000Source | 1,473,000Source | 1,506,000Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | -69,000Source | — | 1,257,000Source | — | — | — |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | -437,000Source | — | 1,384,000Source | — | — | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -278,000Source | -3,247,000Source | -4,770,000Source | -7,990,000Source | -16,112,000Source | -20,827,000Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -1,000Source | — | — | — | -6,000Source | -7,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 1,000Source | — | — | — | 6,000Source | 7,000Source |
| Cash flows from financing activities: | ||||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 105,000Source | 3,646,000Source | 5,264,000Source | 7,822,000Source | 848,000Source | 2,998,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | -166,000Source | 313,000Source | 368,000Source | -241,000Source | -14,967,000Source | -18,214,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | — | 2,982,000Source | — | — | — | — | — | 3,137,000Source | 3,378,000Source | 18,345,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | — | 4,000Source | 7,000Source | — | — | — |
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | — | — | 18,000Source | 2,000Source | 2,000Source | — |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | 6,000Source | 107,000Source | 1,000Source | 7,000Source | 1,000Source | 1,666,000Source | 2,334,000Source | 592,000Source | 1,473,000Source | 1,506,000Source |
| Deconsolidation, Gain (Loss), AmountUSD | — | — | — | — | — | — | — | 4,947,000Source | 4,947,000Source | — | — | — |
| DepreciationUSD | — | — | — | — | — | — | 1,000Source | — | 5,000Source | 6,000Source | 31,000Source | 32,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | — | — | -14,000Source | 2,000Source | -18,000Source | -3,000Source | 39,000Source | -8,000Source | 73,000Source | -54,000Source | -414,000Source | 233,000Source |
| General and Administrative ExpenseUSD | — | — | 1,004,000Source | 1,237,000Source | 497,000Source | 1,249,000Source | 389,000Source | 4,214,000Source | 7,717,000Source | 5,392,000Source | — | — |
| GoodwillUSD | — | — | 1,569,656,000Source | — | 1,570,000Source | — | 1,570,000Source | — | 1,570,000Source | — | — | — |
| Income Tax Expense (Benefit)USD | — | — | — | -210,000Source | 9,000Source | 2,000Source | 30,000Source | — | 7,000Source | -782,000Source | -2,996,000Source | -4,717,000Source |
| Investment Income, InterestUSD | — | — | — | — | — | — | — | — | — | 12,000Source | 266,000Source | 210,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -988,000Source | -1,957,000Source | -405,000Source | -1,318,000Source | -197,000Source | -81,000Source | -2,998,000Source | -11,212,000Source | -22,555,000Source | -21,198,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | -2,503,000Source | -1,957,000Source | -425,000Source | -1,338,000Source | -217,000Source | -81,000Source | -14,092,000Source | -11,212,000Source | — | — |
| Nonoperating Income (Expense)USD | — | — | 4,000Source | 10,000Source | 22,000Source | 1,000Source | 79,000Source | 8,000Source | 5,436,000Source | 10,000Source | -98,000Source | 1,741,000Source |
| Operating ExpensesUSD | — | — | 1,073,000Source | 2,187,000Source | 754,000Source | 1,249,000Source | 1,024,000Source | 4,214,000Source | 9,174,000Source | 12,047,000Source | 25,873,000Source | 27,656,000Source |
| Operating Lease, ExpenseUSD | — | — | — | — | — | — | 13,911Source | 1,176Source | 22,335Source | 82,830Source | 74,218Source | 100,000Source |
| Other Nonoperating Income (Expense)USD | — | — | 9,000Source | — | 31,000Source | 2,000Source | 31,000Source | 10,000Source | 354,000Source | 52,000Source | 50,000Source | — |
| Revenue from Contract with Customer, Including Assessed TaxUSD | — | — | 81,000Source | 10,000Source | 336,000Source | — | 778,000Source | — | 747,000Source | 43,000Source | 420,000Source | 0Source |
| Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, Net of Tax | — | — | — | — | — | —Source | — | —Source | — | — | — | — |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | — | — | — | — | —Source | —Source | —Source | —Source | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | — | — | — | — | 743,000Source | — | 0Source | — | — | — |
| Selling, General and Administrative ExpenseUSD | — | — | — | 1,237,000Source | — | — | — | — | — | 5,392,000Source | 6,718,000Source | 7,382,000Source |
| Operating Income (Loss)USD | — | — | -992,000Source | -2,177,000Source | -418,000Source | -1,249,000Source | -246,000Source | -4,214,000Source | -8,427,000Source | -12,004,000Source | -25,453,000Source | -27,656,000Source |
| Other Nonoperating Income (Expense)USD | — | — | 9,000Source | — | 31,000Source | 2,000Source | 31,000Source | 10,000Source | 354,000Source | 52,000Source | 50,000Source | — |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | -988,000Source | -2,167,000Source | -396,000Source | -1,248,000Source | -167,000Source | -4,206,000Source | -2,991,000Source | -11,994,000Source | -25,551,000Source | -25,915,000Source |
| Income Tax Expense (Benefit)USD | — | — | — | -210,000Source | 9,000Source | 2,000Source | 30,000Source | — | 7,000Source | -782,000Source | -2,996,000Source | -4,717,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -988,000Source | -1,957,000Source | -405,000Source | -1,318,000Source | -197,000Source | -81,000Source | -2,998,000Source | -11,212,000Source | -22,555,000Source | -21,198,000Source |
| Earnings Per Share, BasicUSD per share | — | — | -1.31Source | -43.8Source | — | -0.98Source | — | 0Source | -6.45Source | -504.3Source | — | -1.9Source |
| Earnings Per Share, DilutedUSD per share | — | — | -1.31Source | -43.8Source | — | -0.98Source | — | 0Source | -6.45Source | -504.3Source | — | -1.9Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 1,912,495Source | 44,681Source | 5,598,701Source | 1,360,626Source | 5,458,564Source | 365,231Source | 2,185,075Source | 22,314,000Source | — | 11,255,677Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 1,912,495Source | 44,681Source | 5,598,701Source | 1,360,626Source | 5,458,564Source | 365,231Source | 2,185,075Source | 22,314,000Source | — | 11,255,677Source |
| Additional Financial Items | ||||||||||||
| Costs and ExpensesUSD | — | — | — | — | — | — | — | — | — | — | — | 27,656,000Source |
| Current Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | -7,000Source | 782,000Source | -2,996,000Source | -4,717,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | — | — | -14,000Source | 2,000Source | -18,000Source | -3,000Source | 39,000Source | -8,000Source | 73,000Source | -54,000Source | -414,000Source | 233,000Source |
| General and Administrative ExpenseUSD | — | — | 1,004,000Source | 1,237,000Source | 497,000Source | 1,249,000Source | 389,000Source | 4,214,000Source | 7,717,000Source | 5,392,000Source | — | — |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | — | — | — | — | — | — | — | -1,839,000Source | 36,000Source | -806,000Source | -1,981,000Source |
| Interest Income (Expense), NetUSD | — | — | 9,000Source | 8,000Source | 9,000Source | 2,000Source | 9,000Source | 6,000Source | 62,000Source | — | — | — |
| Investment Income, InterestUSD | — | — | — | — | — | — | — | — | — | 12,000Source | 266,000Source | 210,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | -2,503,000Source | -1,957,000Source | -425,000Source | -1,338,000Source | -217,000Source | -81,000Source | -14,092,000Source | -11,212,000Source | — | — |
| Nonoperating Income (Expense)USD | — | — | 4,000Source | 10,000Source | 22,000Source | 1,000Source | 79,000Source | 8,000Source | 5,436,000Source | 10,000Source | -98,000Source | 1,741,000Source |
| Operating ExpensesUSD | — | — | 1,073,000Source | 2,187,000Source | 754,000Source | 1,249,000Source | 1,024,000Source | 4,214,000Source | 9,174,000Source | 12,047,000Source | 25,873,000Source | 27,656,000Source |
| Operating Lease, ExpenseUSD | — | — | — | — | — | — | 13,911Source | 1,176Source | 22,335Source | 82,830Source | 74,218Source | 100,000Source |
| Preferred Stock Dividends, Income Statement ImpactUSD | — | — | 21,000Source | — | 20,000Source | 20,000Source | 20,000Source | — | 61,000Source | 0Source | 201,000Source | 201,000Source |
| Research and Development ExpenseUSD | — | — | 5,000Source | 950,000Source | — | 68,000Source | — | 822,000Source | 848,000Source | 6,655,000Source | 19,155,000Source | 20,274,000Source |
| Revenue from Contract with Customer, Including Assessed TaxUSD | — | — | 81,000Source | 10,000Source | 336,000Source | — | 778,000Source | — | 747,000Source | 43,000Source | 420,000Source | 0Source |
| Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, Net of Tax | — | — | — | — | — | —Source | — | —Source | — | — | — | — |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | — | — | — | — | —Source | —Source | —Source | —Source | — | — | — | — |
| Income (Loss) from Continuing Operations, Per Basic Share | — | — | — | — | —Source | —Source | —Source | —Source | — | — | — | — |
| Income (Loss) from Continuing Operations, Per Diluted Share | — | — | — | — | —Source | —Source | —Source | —Source | — | — | — | — |
Offerings
Registration 333-299610
Registration 333-296815
Registration 333-288911
Registration 333-288912
Registration 333-286754
Filing attachments
ex107.htm · S-3 · 2026-10-23
Calculation of Filing Fee Tables S-3 Bio Green Med Solution, Inc. ──────────────────────────────────── Table 1: Newly Registered and Carry Forward Securities ☐Not Applicable ─────────────────────────────────────────────────────────────────────────────── Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate O…
Read attachment ↗ex99-1.htm · S-4/A · 2026-09-11
Exhibit 99.1 BIO GREEN MED SOLUTION, INC. FORM OF PROXY CARD SPECIAL MEETING OF STOCKHOLDERS To Be Held on November 19,2026 at 12:30 p.m., Eastern Time Virtual Meeting THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS The undersigned stockholder of Bio Green Med Solution, Inc., a Delaware corporation (“BGMS” or the “Company”), hereby appoints Datuk Dr. Doris Wong and Ian Hanna, or either of them, as proxies for the undersigned, with full power of substitution in each of them, t…
Read attachment ↗ex99-1.htm · S-4/A · 2026-08-21
EX-99.1 4 ex99-1.htm EX-99.1 Exhibit 99.1 BIO GREEN MED SOLUTION, INC. FORM OF PROXY CARD SPECIAL MEETING OF STOCKHOLDERS To Be Held on [●], 2026 at [●] [a.m./p.m.], Eastern Time Virtual Meeting THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS The undersigned stockholder of Bio Green Med Solution, Inc., a Delaware corporation (“BGMS” or the “Company”), hereby appoints [●] and [●], or either of them, as proxies for the undersigned, with full power of substitution in each of…
Read attachment ↗ex99-1.htm · 8-K · 2026-08-14
EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 BIO GREEN MED SOLUTION Reports SECOND quarter financial results and provides business update KUALA LUMPUR, MALAYSIA, August 12, 2026 - Bio Green Med Solution, Inc. (NASDAQ: BGMS; “BGMS” or the “Company”), a diversified company engaged primarily in the provision of fire safety protection and distribution activities, today announced second quarter financial results and provided a business update. Highlights of the second quarter ended June 30, 2026,…
Read attachment ↗ex107.htm · S-4 · 2026-06-16
Calculation of Filing Fee Tables S-4 Bio Green Med Solution, Inc. ──────────────────────────────────── Table 1: Newly Registered and Carry Forward Securities ☐Not Applicable ─────────────────────────────────────────────────────────────────────────────── Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate O…
Read attachment ↗ex99-1.htm · 425 · 2026-06-04
Exhibit 99.1 Bio Green Med Solution, INC. Announces Business Combination Agreement to acquire Future NRG Sdn. Bhd. Creation of a next-generation environmental platform: The proposed transaction brings together essential safety and environmental services, with a strategic focus on regulatory-driven industries where compliance, technical expertise, and reliability are paramount, into a single, globally scalable platform. Integrated fuels, infrastructure, and environmental markets: Th…
Read attachment ↗